Hi Hector,
Not sure if you are aware but Prochymal has proven to be ineffective for a number of trials , including;
graft-versus-host disease, knee cartilage repair, Crohn's disease ( related to Bone Marrow transplants); heart attack and now diabetes.
IMO, Mesobalast can be differentiated from Osiris by :
(a) The depth of the pre-cinical trials conducted by MSB Before they proceed to Clinical;
(b) Osiris's platform technology is based on mesenchymal stem cells (MSCs) where as Mesoblast uses the earliest and rarest progenitor stem cell found in the adult called a Mesenchymal Precursor Cell (MPCs)
(c) Based on the above Mesoblast’s technology positively selects for a starting population of MPCs which is more than 1000-fold purer than that of its competitors ( see MSB website)
In my view, the above partly explains why MSB has to date two(2) Statistically significant outcomes:-
>>Bone Marrow Translants - Phase III
>>Congestive Heart Failure - Phase II
I think your comment is fair enough comment but what also needs to be noted is that unfortunately for Osiris there havent been any notable ( Statiscically significant) Phase II outcomes to date.
The above is IMO only.
Cheers
- Forums
- ASX - By Stock
- MSB
- competitor does not cut the mustard
competitor does not cut the mustard, page-5
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
Add MSB (ASX) to my watchlist
|
|||||
Last
97.0¢ |
Change
-0.025(2.51%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
97.0¢ | $1.01 | 96.5¢ | $7.757M | 7.884M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 274918 | 97.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 974 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 103162 | 0.970 |
5 | 34741 | 0.965 |
11 | 125566 | 0.960 |
1 | 500 | 0.955 |
22 | 165429 | 0.950 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 974 | 1 |
0.990 | 10204 | 1 |
1.000 | 14000 | 1 |
1.010 | 2877 | 1 |
1.015 | 60000 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |